Subscribe
The best therapy today for malaria is a drug combination that includes a derivative of artemisinin, now solely available from plants. On April 11, Sanofi began production of the first semi-synthetic version of artemisinin, derived from yeast developed by biotech company Amyris based on discoveries in the laboratory of Jay Keasling at UC Berkeley.
Tag: drugs
Howard Hughes Medical Institute names three new campus investigators
May 9, 2013:
Three young faculty members – Nicole King, Michael Rape & Russell Vance – have won the most sought-after appointment for a researcher at any American university: as a Howard Hughes Medical Institute investigator. The institute will pay their salaries in the Department of Molecular & Cell Biology and provide research funding, freeing them from constant application for federal research grants.
Malaria milestone ‘took a village’
April 25, 2013:
On April 25, World Malaria Day, the non-profit Zagaya released a video Illustrating why, in the words of UC Berkeley synthetic biologist Jay Keasling, “it took a village” to create an accessible treatment for malaria that will be essential to eradicating the disease.
Tinnitus discovery could lead to new ways to stop the ringing
September 12, 2011:
People with tinnitus – a constant ringing or buzzing in the ears – can take heart from a new study by UC Berkeley neuroscientists that points to several new strategies for alleviating the problem.
Legalize marijuana? Pro, con, or undecided, Berkeley students sound off on Prop. 19
October 19, 2010:
On Nov. 2, state voters will decide on a controversial and quintessentially California ballot measure, Proposition 19, the “Regulate, Control and Tax Cannabis Act of 2010.” Where do students at Berkeley, with its reputation for liberalism (accurate or not) come down on the issue? Eleven campus undergraduates think out loud about the pros and cons of Prop. 19.
